The DOI matches its Crossref record, with a small difference in title or year; 251 of the 252 references it cites were found in a registry or an index.
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Open accessAbstract
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle with preserved or increased ejection fraction. It is commonly asymmetrical with the most severe hypertrophy involving the basal interventricular septum. Left ventricular outflow tract obstruction is present at rest in about one third of the patients and can be provoked in another third. The histological features of HCM include myocyte hypertrophy and disarray, as well as interstitial fibrosis. The hypertrophy is also frequently associated with left ventricular diastolic dysfunction. In the majority of patients, HCM has a relatively benign course. However, HCM is also an important cause of sudden cardiac death, particularly in adolescents and young adults. Nonsustained ventricular tachycardia, syncope, a family history of sudden cardiac death, and severe cardiac hypertrophy are major risk factors for sudden cardiac death. This complication can usually be averted by implantation of a cardioverter-defibrillator in appropriate high-risk patients. Atrial fibrillation is also a common complication and is not well tolerated. Mutations in over a dozen genes encoding sarcomere-associated proteins cause HCM. MYH7 and MYBPC3 , encoding β-myosin heavy chain and myosin-binding protein C, respectively, are the 2 most common genes involved, together accounting for ≈50% of the HCM families. In ≈40% of HCM patients, the causal genes remain to be identified. Mutations in genes responsible for storage diseases also cause a phenotype resembling HCM (genocopy or phenocopy). The routine applications of genetic testing and preclinical identification of family members represents an important advance. The genetic discoveries have enhanced understanding of the molecular pathogenesis of HCM and have stimulated efforts designed to identify new therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This clinical variability can, in part, be explained by the influence of modifiable cardiometabolic risk factors, such as obesity, diabetes, and hypertension [6].”
From Association of GLP-1 receptor agonist use with cardiovascular outcomes in patients with non-obstructive hypertrophic cardiomyopathy (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Hypertrophic cardiomyopathy (HCM) is characterized by cardiac hypertrophy, a non-dilated left ventricle (LV), and a normal or increased EF.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–251 of 251
McLellan, A. J. A., Ellims, A., Prabhu, S., Voskoboinik, A., Iles, L., Hare, J., Kaye, D. M., Macciocca, I., Mariani, J. A., Kalman, J. M., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12948 · Cited by 71
Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy
Towe, E., Bos, J. M., Ommen, S. R., Gersh, B. J., & Ackerman, M. J. (2014) · Congenital Heart Disease · doi:10.1111/chd.12242 · Cited by 70
Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy
Daw, E. W., Chen, S. N., Czernuszewicz, G., Lombardi, R., Lu, Y., Ma, J., Roberts, R., Shete, S., & Marian, A. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm202 · Cited by 70
Self-citationLandstrom, A. P., Adekola, B. A., Bos, J. M., Ommen, S. R., & Ackerman, M. J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.08.001 · Cited by 69
Myosin isoforms and the mechanochemical cross-bridge cycle
Walklate, J., Ujfalusi, Z., & Geeves, M. A. (2016) · Journal of Experimental Biology · doi:10.1242/jeb.124594 · Cited by 69
5′RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy
Christodoulou, D. C., Wakimoto, H., Onoue, K., Eminaga, S., Gorham, J., DePalma, S. R., Herman, D. S., Teekakirikul, P., Conner, D. A., McKean, D. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70108 · Cited by 68
Ho, C. Y., Day, S. M., Colan, S. D., Russell, M. W. W., Towbin, J. A., Sherrid, M. V., Canter, C. E., Jefferies, J. L., Murphy, A. M., Cirino, A. L., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.5670 · Cited by 65
Modern Imaging Techniques in Cardiomyopathies
Jan, M. F., & Tajik, A. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.309600 · Cited by 64
Chapman, K. B., Solomon, S. D., & Boeke, J. D. (1992) · Gene · doi:10.1016/0378-1119(92)90260-v · Cited by 63
Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy
Tripathi, S., Schultz, I., Becker, E., Montag, J., Borchert, B., Francino, A., Navarro‐López, F., Perrot, A., Özcelik, C., Osterziel, K. J., et al. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0205-9 · Cited by 63
Kuster, D. W. D., Mulders, J., ten Cate, F. J., Michels, M., dos Remedios, C. G., Martins, P. A. D. C., van der Velden, J., & Oudejans, C. B. M. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.09.012 · Cited by 62
Almaas, V. M., Haugaa, K. H., Strøm, E. H., Scott, H., Dahl, C. P., Leren, T. P., Geiran, O. R., Endresen, K., Edvardsen, T., Aakhus, S., et al. (2013) · EP Europace · doi:10.1093/europace/eut028 · Cited by 62
Familial hypertrophic cardiomyopathy: Functional effects of myosin mutation R723G in cardiomyocytes
Kraft, T., Witjas‐Paalberends, E. R., Boontje, N. M., Tripathi, S., Brandis, A., Montag, J., Hodgkinson, J. L., Francino, A., Navarro‐López, F., Brenner, B., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.001 · Cited by 61
A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder
Li, L., Bainbridge, M. N., Tan, Y., Willerson, J. T., & Marian, A. J. (2017) · Circulation Research · doi:10.1161/circresaha.116.310559 · Cited by 61
Self-citationBloemink, M. J., Deacon, J. C., Langer, S. J., Vera, C. D., Combs, A. C., Leinwand, L. A., & Geeves, M. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511204 · Cited by 60
Sommese, R. F., Nag, S., Sutton, S. C., Miller, S. M., Spudich, J. A., & Ruppel, K. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083403 · Cited by 58
Lombardi, R., Bell, A., Senthil, V., Sidhu, J. S., Noseda, M., Roberts, R., & Marian, A. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn078 · Cited by 58
Self-citationHo, C. Y., McMurray, J. J. V., Cirino, A. L., Colan, S. D., Day, S. M., Desai, A. S., Lipshultz, S. E., MacRae, C. A., Shi, L., Solomon, S. D., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.02.008 · Cited by 58
Nagueh, S. F. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.02.010 · Cited by 53
Kraft, T., Montag, J., Radocaj, A., & Brenner, B. (2016) · Circulation Research · doi:10.1161/circresaha.116.309804 · Cited by 53
Zen, K., Irie, H., Doue, T., Takamiya, M., Yamano, T., Sawada, T., Azuma, A., & Matsubara, H. (2005) · International Heart Journal · doi:10.1536/ihj.46.231 · Cited by 52
Ruggiero, A., Chen, S. N., Lombardi, R., Rodrı́guez, G., & Marian, A. J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs294 · Cited by 52
Self-citationEllims, A., Taylor, A. J., Mariani, J. A., Ling, L., Iles, L., Maeder, M. T., & Kaye, D. M. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000665 · Cited by 52
Marian, A. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01389-4 · Cited by 51
Self-citationMicroarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy
Yang, W., Li, Y., He, F., & Wu, H. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0056-7 · Cited by 51
Gupte, T. M., Haque, F., Gangadharan, B., Sunitha, M. S., Mukherjee, S., Anandhan, S., Rani, D. S., Mukundan, N., Jambekar, A. A., Kumarasamy Thangaraj, K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596676 · Cited by 51
Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy
Sasagawa, S., Nishimura, Y., Okabe, S., Murakami, S., Ashikawa, Y., Yuge, M., Kawaguchi, K., Kawase, R., Okamoto, R., Ito, M., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00162 · Cited by 51
Hartmannová, H., Kubánek, M., Šramko, M., Piherová, L., Nosková, L., Hodaňová, K., Stránecký, V., Přistoupilová, A., Sovová, J., Marek, T., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000245 · Cited by 47
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study
Nagueh, S. F., Lombardi, R., Tan, Y., Wang, J., Willerson, J. T., & Marian, A. J. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02349.x · Cited by 41
Self-citationNature’s Genetic Gradients and the Clinical Phenotype
Marian, A. J. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.921940 · Cited by 40
Self-citationMarian, A. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.302904 · Cited by 39
Self-citationRAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy
Kaufman, B. D., Auerbach, S. R., Reddy, S., Manlhiot, C., Deng, L., Prakash, A., Printz, B. F., Gruber, D., Papavassiliou, D. P., Hsu, D. T., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0429-9 · Cited by 38
Wolny, M., Colegrave, M., Colman, L., White, E., Knight, P. J., & Peckham, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.513291 · Cited by 36
Maron, B. J., Rowin, E. J., Maron, M. S., & D, E. B. M. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.09.015 · Cited by 36
Genetic heterogeneity of hypertrophic cardiomyopathy
Branzi, A., Romeo, G. C., Specchia, S., Lolli, C., Binetti, G. G., Devoto, M., Reggiani, M. L. B., & Magnani, B. (1985) · International Journal of Cardiology · doi:10.1016/0167-5273(85)90352-3 · Cited by 35
Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
Blair, E. M., Price, S. J., Baty, C. J., Östman‐Smith, I., & Watkins, H. C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.6.385 · Cited by 35
Frey, N., Brixius, K., Schwinger, R. H. G., Benis, T., Karpowski, A., Lorenzen, H. P., Luedde, M., Katus, H. A., & Franz, W. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507740200 · Cited by 31
MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients
Mouton, J., van der Merwe, L., Goosen, A., Revera, M., Brink, P. A., Moolman‐Smook, J. C., & Kinnear, C. J. (2016) · Human Genetics · doi:10.1007/s00439-016-1649-7 · Cited by 31
Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis
Seo, J., Kim, M., Hong, G., Kim, D., Son, J., Cho, I. J., Shim, C. Y., Chang, H., Ha, J., & Chung, N. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.52 · Cited by 31
Hodatsu, A., Konno, T., Hayashi, K., Funada, A., Fujita, T., Nagata, Y., Fujino, N., Kawashiri, M., & Yamagishi, M. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00637.2013 · Cited by 29
Lim, D., Oberst, L., McCluggage, M., Youker, K. A., Lacy, J. L., DeMayo, F. J., Entman, M. L., Roberts, R., Michael, L. H., & Marian, A. J. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1081 · Cited by 29
Self-citationSolaro, R. J., Varghese, J., Marian, A. J., & Chandra, M. (2002) · Basic Research in Cardiology · doi:10.1007/s003950200038 · Cited by 23
Self-citationRevera, M., van der Merwe, L., Heradien, M. J., Goosen, A., Corfield, V. A., Brink, P. A., & Moolman‐Smook, J. C. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm075 · Cited by 22
Cohen, L. S., & D, E. B. M. (1968) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(68)90011-x · Cited by 21
Challenges in the Diagnosis of Anderson-Fabry Disease
Marian, A. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.026 · Cited by 21
Self-citationThe Case of “Missing Causal Genes” and the Practice of Medicine
Marian, A. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.308830 · Cited by 18
Self-citationGrazioli, G. C., Usín, D., Trucco, E., Sanz, M., Montserrat, S., Vidal, B., Gutiérrez, J. A., Canal, R., Brugada, J., Mont, L., et al. (2016) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2016.03.005 · Cited by 16
Malik, R., Maron, M. S., Rastegar, H., & Pandian, N. G. (2014) · Echocardiography · doi:10.1111/echo.12543 · Cited by 15
Kadota, C., Arimura, T., Hayashi, T., Naruse, T. K., Kawai, S., & Kimura, A. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.81 · Cited by 12
An internal domain of β-tropomyosin increases myofilament Ca2+sensitivity
Jagatheesan, G., Rajan, S., Schulz, E. M., Ahmed, R. P. H., Petrashevskaya, N. N., Schwartz, A., Boivin, G. P., Arteaga, G. M., Wang, T., Wang, Y.-G., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00329.2008 · Cited by 11
Cordero‐Reyes, A. M., Youker, K. A., Hamilton, D. J., Torre‐Amione, G., Marian, A. J., & Nagueh, S. F. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.972802 · Cited by 8
Self-citation
Flagged first, then by citations
1 of the 252 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- 10.1161/01.CIR.104.3.317 · DOI
- BROCK R. Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis). Guys Hosp Rep. 1959;108:126–143.
Cited by
Sorted by citations
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,709
Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31792-x · Cited by 1,296
Self-citationOmmen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 997
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Metadata
- Authors
- Marian, A. J., & Braunwald, E.
- Affiliations
- Brigham and Women's Hospital (US)
- From the Center for Cardiovascular Genetics, Institute of Molecular Medicine, Department of Medicine, University of Texas Health Sciences Center at Houston (A.J.M.); Texas Heart Institute, Houston (A.J.M.); and TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (E.B.).
- ORCID
- Marian, Ali J.
- Venue
- Circulation Research
- Published
- 2017-09-15
- Volume
- 121
- Issue
- 7
- Pages
- 749-770
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC5654557
- OpenAlex
- W2756203218
- Cited by
- 1,403
- References
- 252
- Citations by year
- 2026: 175 · 2025: 226 · 2024: 219 · 2023: 199 · 2022: 153 · 2021: 174 · 2020: 103 · 2019: 83 · 2018: 61 · 2017: 6
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL088498, R01HL132401)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, left ventricular hypertrophy, left ventricular outflow tract obstruction, sudden cardiac death, non-sustained ventricular tachycardia, syncope, cardioverter-defibrillator implantation, atrial fibrillation, sarcomere gene mutations, MYH7, MYBPC3, genetic testing, phenocopy, storage diseases, left ventricular diastolic dysfunction, interstitial fibrosis, molecular pathogenesis
- MeSH terms
- Animals, Biopsy, Cardiomyopathy, Dilated, DNA Mutational Analysis, Genetic Markers, Humans, Mutation, Myocardium, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, Ventricular Function, Left, Risk Assessment, Genetic Predisposition to Disease, Molecular Diagnostic Techniques, Cardiac Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
